10/09/2026
We are incredibly proud to support Roswell Park Comprehensive Cancer Center and their cutting edge cancer research. Check this out! Research that our community supports. 👏💪🏒🎗️
🚨 Encouraging news in the fight against glioblastoma!
We’re proud to share promising results from the SURVIVE trial evaluating SurVaxM, an investigational immunotherapeutic vaccine for newly diagnosed glioblastoma, in partnership with MimiVax.
For patients 65 and under, the results are especially encouraging:
🧠 Statistically significant overall survival benefit
📈 Approximately double the survival compared with placebo
💙 About 42% of patients remained alive at 30 months or longer
These results represent an important milestone in a disease where meaningful treatment advances have been so difficult to achieve.
And YOU helped make this possible.
The SurVaxM research team is deeply grateful to the donors who have supported the Roswell Park Alliance Foundationand events like the Ride for Roswell and Empire State Ride over the years. That generosity provided critical seed funding that helped this promising immunotherapy advance to this stage.
Your support fuels discovery. Your generosity helps move cancer research forward. And your belief in a better future makes a difference.
Read more about the SURVIVE trial results: https://www.roswellpark.org/newsroom/202610-mimivax-roswell-park-announce-results-phase-2b-survive-trial-survaxm-newly
